Clinical Trial Update: PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment [Phase 1]

View source ↗

Summary

Phase 1 trial of PU-H71 in patients with solid tumors and low-grade non-Hodgkin's lymphoma that failed standard therapy; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• PU-H71 (PU-H71)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Solid Tumors, Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2017-10-04